Effects of Oxygen After Abdominal Oncological Surgery
EPHIRAS
Exploring Postoperative Effects of Hyperoxic Intermittent Stimuli on Reticulocytes Levels in Abdominal Surgery: A Randomized Single-blind Study
1 other identifier
interventional
49
1 country
1
Brief Summary
The aims of the research is to determine whether a Hyperoxic intermittent stimuli protocol can increase reticulocyte counts, signififying a rise in EPO production, in patients undergoing abdominal surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 22, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedApril 10, 2024
February 1, 2024
10 months
February 22, 2024
April 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage change in reticulocyte count
Percentage change in reticulocyte count from baseline to day six within each group
6 days
Secondary Outcomes (2)
haematocrit levels mesure
6 days
haemoglobin levels mesure
6 days
Study Arms (2)
Normobaric Oxygen Paradox (NOP) group
EXPERIMENTALThe NOP group received 60% oxygen for two hours on days 1, 3, and 5 post-surgery using a venti-mask.
Control (CTR) group
NO INTERVENTIONThe CTR group did not receive oxygen therapy during the post-operatory period starting from day 1.
Interventions
Eligibility Criteria
You may qualify if:
- patients undergoing abdominal oncological surgery
You may not qualify if:
- GFR\<60 ml/minute and/ or creatinine serum level \> 2mg/dl
- Transfusion of red blood cells per or postoperatively
- Bleeding requiring repeated transfusions during or after surgery
- Severe respiratory syndrome necessitating continuous oxygen
- Intolerance to oxygen mask
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Khalife Maher
Brussels, 1000, Belgium
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maher Khalife, MD
Jules Bordet Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- The belonging to one group or the other was blinded to the laboratory staff.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2024
First Posted
March 20, 2024
Study Start
January 1, 2011
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
April 10, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share